Aehr Test Systems (AEHR) Expected to Announce Quarterly Earnings on Monday

Key Points

• Aehr Test Systems is set to release its Q1 2026 earnings on October 6th, with expectations of $0.01 earnings per share and $11.465 million in revenue.
• The company's last earnings report showed a loss of ($0.01) per share and a revenue of $14.10 million, slightly below analyst expectations.
• Insider selling has been notable, with significant shares sold by directors and VPs, indicating changes in ownership stakes among executives.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) is expected to issue its Q1 2026 results after the market closes on Monday, October 6th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $11.4650 million for the quarter. Parties are encouraged to explore the company's upcoming Q1 2026 earningoverview page for the latest details on the call scheduled for Monday, October 6, 2025 at 5:00 PM ET.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The company had revenue of $14.10 million during the quarter, compared to analyst estimates of $14.83 million. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. On average, analysts expect Aehr Test Systems to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Aehr Test Systems Stock Performance

Aehr Test Systems stock opened at $30.11 on Wednesday. The firm has a market cap of $902.40 million, a price-to-earnings ratio of -231.60 and a beta of 2.54. Aehr Test Systems has a 1 year low of $6.27 and a 1 year high of $34.10. The firm's 50 day moving average price is $23.68 and its two-hundred day moving average price is $14.98.

Insider Buying and Selling

In related news, Director Rhea J. Posedel sold 18,000 shares of the company's stock in a transaction on Tuesday, July 22nd. The stock was sold at an average price of $19.83, for a total value of $356,940.00. Following the completion of the transaction, the director directly owned 71,163 shares in the company, valued at approximately $1,411,162.29. This represents a 20.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Alistair N. Sporck sold 3,000 shares of Aehr Test Systems stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $14.13, for a total value of $42,390.00. Following the transaction, the vice president directly owned 30,808 shares of the company's stock, valued at approximately $435,317.04. The trade was a 8.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,000 shares of company stock worth $506,830. Insiders own 6.80% of the company's stock.

Institutional Trading of Aehr Test Systems

Several hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. increased its stake in Aehr Test Systems by 1.9% in the 2nd quarter. Osaic Holdings Inc. now owns 63,608 shares of the semiconductor company's stock valued at $822,000 after buying an additional 1,210 shares during the last quarter. Rhumbline Advisers grew its holdings in shares of Aehr Test Systems by 3.1% during the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company's stock worth $536,000 after purchasing an additional 1,254 shares during the last quarter. Royal Bank of Canada boosted its holdings in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company's stock valued at $365,000 after acquiring an additional 36,364 shares during the last quarter. American Century Companies Inc. increased its holdings in Aehr Test Systems by 88.1% in the second quarter. American Century Companies Inc. now owns 22,106 shares of the semiconductor company's stock worth $286,000 after purchasing an additional 10,354 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Aehr Test Systems by 7.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company's stock worth $201,000 after buying an additional 1,145 shares in the last quarter. Institutional investors and hedge funds own 69.69% of the company's stock.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.